Medication used for the treatment of migraine headaches
Pharmaceutical compound
Rizatriptan Trade names Maxalt, Maxalt-MLT, Rizafilm, others Other names L-705126; L705126; MK-0462; MK0462; MK-462; MK462; 5-(1H -1,2,4-Triazol-1-ylmethyl)-N ,N -dimethyltryptamine; 5-(1H -1,2,4-Triazol-1-ylmethyl)-DMT AHFS /Drugs.com Monograph MedlinePlus a601109 License data
Pregnancy category Routes of administration By mouth Drug class Serotonin 5-HT1B , 5-HT1D , 5-HT1E , and 5-HT1F receptor agonist ; Antimigraine agent ; Triptan ATC code Legal status
Bioavailability 45% Protein binding 14% Metabolism By monoamine oxidase Elimination half-life 2–3 hours Excretion 82% urine ; 12% feces
N ,N -dimethyl-2-[5-(1H -1,2,4-triazol-1-ylmethyl)-1H -indol-3-yl]ethanamine
CAS Number PubChem CID IUPHAR/BPS DrugBank ChemSpider UNII KEGG ChEBI ChEMBL CompTox Dashboard (EPA ) ECHA InfoCard 100.243.719 Formula C 15 H 19 N 5 Molar mass 269.352 g·mol−1 3D model (JSmol )
n1cncn1Cc2cc3c(cc2)[nH]cc3CCN(C)C
InChI=1S/C15H19N5/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3
Y Key:ULFRLSNUDGIQQP-UHFFFAOYSA-N
Y
(verify)
Rizatriptan , sold under the brand name Maxalt among others, is a medication used for the treatment of migraine headaches .[ 1] [ 3] It is taken by mouth .[ 1] [ 3] It can also be applied on the tongue.[ 2] It is a serotonin (5-HT) 1B/1D receptor agonist (triptan).[ 1] [ 2]
Common side effects include chest pain , dizziness, dry mouth, and tingling.[ 3] Other side effects may include myocardial infarction , stroke , high blood pressure , serotonin syndrome , and anaphylaxis .[ 3] Excessive use may result in medication overuse headaches .[ 3] Use is not recommended during pregnancy and breastfeeding is not recommended within 24 hours after taking a dose.[ 4] Rizatriptan is in the triptan class and is believed to work by activating the 5-HT1 receptor .[ 3]
Rizatriptan was patented in 1991 and came into medical use in 1998.[ 5] [ 6] It is available as a generic medication .[ 4] In 2023, it was the 208th most commonly prescribed medication in the United States, with more than 2 million prescriptions.[ 7] [ 8] Rizatriptan is available in combination with meloxicam as meloxicam/rizatriptan .
Medical uses
Rizatriptan is indicated to treat acute migraine attacks with or without aura .[ 1] [ 2] It does not prevent future migraine attacks.[ 9] A 2010 review found rizatriptan to be more efficacious and tolerable than sumatriptan.[ 10]
Contraindications
Rizatriptan and other triptans can cause vasoconstriction, they are contraindicated in people with cardiovascular conditions.[ 11]
Adverse effects
Frequent adverse effects (incidence less than 10%) are dizziness, drowsiness, asthenia/fatigue, and nausea. Clinical adverse experiences were typically mild and short-lasting (2–3 hours).[ 11]
Interactions
Rizatriptan has an important but complex interaction with a metabolite of the beta blocker propranolol .[ 12] This interaction involves the enzyme monoamine oxidase A (MAO-A).[ 12] Due to the interaction, the dose of rizatriptan should be reduced to 5 mg when it is combined with propranolol.[ 12]
Pharmacology
Mechanism of action
Rizatriptan activities
Target
Affinity (Ki , nM)
5-HT1A
48–500 (Ki ) >10,000 (EC50 Tooltip half-maximal effective concentration ) 40% (Emax Tooltip maximal efficacy )
5-HT1B
3–138 (Ki ) 1.4–234 (EC50 ) 74–99% (Emax )
5-HT1D
1.5–138 (Ki ) 1.6–16 (EC50 ) 83–105% (Emax )
5-HT1E
87–316 (Ki ) 6.8–870 (EC50 ) 107% (Emax )
5-HT1F
138–5,370 (Ki ) 4.2–2,540 (EC50 ) 93% (Emax )
5-HT2A
>10,000 (Ki ) >10,000 (EC50 )
5-HT2B
257–3,090 (Ki ) 3,240 (EC50 )
5-HT2C
>3,160 (Ki )ND (EC50 )
5-HT3
>3,160 (mouse)
5-HT4
>3,160 (guinea pig)
5-HT5A
5,500 (rat)
5-HT6
>3,160
5-HT7
1,860–>10,000 (Ki ) >10,000 (EC50 )
α1A –α1D
ND
α2A –α2C
ND
β1 –β3
ND
D1 –D5
ND
H1 –H4
ND
M1 –M5
ND
I1 , I2
ND
σ1 , σ2
ND
TAAR1 Tooltip Trace amine-associated receptor 1
ND
SERT Tooltip Serotonin transporter
ND
NET Tooltip Norepinephrine transporter
ND
DAT Tooltip Dopamine transporter
ND
Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified. Refs: [ 13] [ 14] [ 15] [ 16] [ 17] [ 18] [ 19] [ 20] [ 21] [ 22] [ 23] [ 24] [ 25] [ 26]
Rizatriptan acts as an agonist at serotonin 5-HT1B and 5-HT1D receptors.[ 27] Like the other triptans sumatriptan and zolmitriptan , rizatriptan induces vasoconstriction —possibly by inhibiting the release of calcitonin gene-related peptide from sensory neurons in the trigeminal nerve .[ 27]
Chemistry
Rizatriptan, also known as 5-(1H -1,2,4-triazol-1-ylmethyl)-N ,N -dimethyltryptamine, is a tryptamine derivative and a 5-substituted derivative of the psychedelic drug dimethyltryptamine (DMT).[ 28]
The experimental log P of rizatriptan is 1.4 and its predicted log P is 1.67 to 1.77.[ 28] [ 29]
History
Rizatriptan was patented in 1991 and was introduced for medical use in 1998.[ 5] [ 6]
Society and culture
Brand names
Brand names include Rizalt, Rizalt RPD, Rizact (India), Rizafilm,[ 2] Maxalt,[ 1] and Maxalt-MLT.[ 1] [ 30] [ 31] [ 32]
References
^ a b c d e f g "Maxalt- rizatriptan benzoate tablet; Maxalt-MLT- rizatriptan benzoate tablet, orally disintegrating" . DailyMed . 1 June 2022. Archived from the original on 23 March 2023. Retrieved 25 December 2023 .
^ a b c d e "Archived copy" (PDF) . Archived from the original (PDF) on 2 August 2023. Retrieved 25 December 2023 .{{cite web }}
: CS1 maint: archived copy as title (link )
^ a b c d e f "Rizatriptan Benzoate Monograph for Professionals" . Drugs.com . American Society of Health-System Pharmacists. Archived from the original on 23 October 2020. Retrieved 18 March 2019 .
^ a b British National Formulary: BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 473. ISBN 9780857113382 .
^ a b "Drug Approval Package: Maxalt/Rizatritan Benzoate NDA# 20864 & 20865" . U.S. Food and Drug Administration (FDA). 30 March 2001. Archived from the original on 6 December 2022. Retrieved 25 December 2023 .
^ a b Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery . John Wiley & Sons. p. 531. ISBN 9783527607495 .
^ "The Top 300 of 2023" . ClinCalc . Archived from the original on 12 August 2025. Retrieved 12 August 2025 .
^ "Rizatriptan Drug Usage Statistics, United States, 2013 - 2023" . ClinCalc . Retrieved 20 August 2025 .
^ "Rizatriptan" . MedlinePlus . U.S. National Library of Medicine. Archived from the original on 5 July 2016. Retrieved 21 March 2018 .
^ Göbel H (2010). "Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis". Expert Rev Neurother . 10 (4): 499– 506. doi :10.1586/ern.10.24 . PMID 20367203 . S2CID 43395810 .
^ a b Hargreaves RJ, Lines CR, Rapoport AM, Ho TW, Sheftell FD (2009). "Ten years of rizatriptan: from development to clinical science and future directions". Headache . 49 : S3 – S20 . doi :10.1111/j.1526-4610.2008.01335.x . PMID 19161563 . S2CID 23587019 .
^ a b c Millson DS, Tepper SJ, Rapoport AM (March 2000). "Migraine pharmacotherapy with oral triptans: a rational approach to clinical management". Expert Opinion on Pharmacotherapy . 1 (3): 391– 404. doi :10.1517/14656566.1.3.391 . PMID 11249525 . S2CID 36053513 .
^ Liu T. "BindingDB BDBM50033437 CHEMBL905::MK 462 free base::N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine::N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine::N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine::RIZATRIPTAN::risatriptan" . BindingDB . Retrieved 13 July 2025 .
^ De Vries P, Villalón CM, Saxena PR (1999). "Pharmacology of triptans". Emerging Drugs . 4 (1): 107– 125. doi :10.1517/14728214.4.1.107 . ISSN 1361-9195 .
^ Tfelt-Hansen P, De Vries P, Saxena PR (December 2000). "Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy". Drugs . 60 (6): 1259– 1287. doi :10.2165/00003495-200060060-00003 . PMID 11152011 .
^ Deleu D, Hanssens Y (July 2000). "Current and emerging second-generation triptans in acute migraine therapy: a comparative review". J Clin Pharmacol . 40 (7): 687– 700. doi :10.1177/00912700022009431 . PMID 10883409 .
^ Saxena PR, Tfelt-Hansen P (2001). "Success and failure of triptans" . The Journal of Headache and Pain . 2 (1): 3– 11. doi :10.1007/s101940170040 . ISSN 1129-2369 . PMC 3611827 .
^ van den Brink M (22 December 1999). "Coronary Side Effects of Antimigraine Drugs From Patient to Receptor" . RePub, Erasmus University Repository . Retrieved 19 June 2025 . Table 1.2 Receptor binding properties (pKi values) of sumatriptan and second-generation triptans at 5-HT receptors. [...]
^ van den Broek RW (13 March 2002). "Vascular Effects of Antimigraine Drugs: pharmacology of human in vitro models in migraine" . RePub, Erasmus University Repository . Retrieved 19 June 2025 . Table 1.2 Receptor binding properties (pKi values) of the triptans at human 5-HT receptors. [...]
^ Pauwels PJ, Tardif S, Palmier C, Wurch T, Colpaert FC (1997). "How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines". Neuropharmacology . 36 (4– 5): 499– 512. doi :10.1016/s0028-3908(96)00170-0 . PMID 9225275 .
^ Nelson DL, Phebus LA, Johnson KW, Wainscott DB, Cohen ML, Calligaro DO, et al. (October 2010). "Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan". Cephalalgia . 30 (10): 1159– 1169. doi :10.1177/0333102410370873 . PMID 20855361 .
^ Rubio-Beltrán E, Labastida-Ramírez A, Haanes KA, van den Bogaerdt A, Bogers AJ, Zanelli E, et al. (December 2019). "Characterization of binding, functional activity, and contractile responses of the selective 5-HT1F receptor agonist lasmiditan" . British Journal of Pharmacology . 176 (24): 4681– 4695. doi :10.1111/bph.14832 . PMC 6965684 . PMID 31418454 . TABLE 1 Summary of pIC50 (negative logarithm of the molar concentration of these compounds at which 50% of the radioligand is displaced) and pKi (negative logarithm of the molar concentration of the Ki ) values of individual antimigraine drugs at 5‐HT receptors [...] TABLE 2 Summary of pEC50 values of cAMP (5‐HT1A/B/E/F and 5‐HT7), GTPγS (5‐HT1A/B/D/E/F), and IP (5‐HT2) assays of individual antimigraine drugs at 5‐HT receptors [...]
^ Perez, M., Halazy, S., Pauwels, P.J., Colpaert, F.C., John, G.W. (1999). "F-11356" . Drugs of the Future . 24 (6): 0605. doi :10.1358/dof.1999.024.06.537284 . Retrieved 23 June 2025 .
^ Reuter U, Neeb L (2012). "Lasmiditan hydrochloride" . Drugs of the Future . 37 (10): 709. doi :10.1358/dof.2012.037.010.1873629 . ISSN 0377-8282 . Retrieved 19 June 2025 .
^ Mitsikostas DD, Ward TN (2024). "Evidence-based symptomatic treatment of migraine". Migraine Management . Handbook of Clinical Neurology. Vol. 199. pp. 203– 218. doi :10.1016/B978-0-12-823357-3.00004-5 . ISBN 978-0-12-823357-3 . PMID 38307647 .
^ Comer MB (April 2002). "Pharmacology of the selective 5-HT(1B/1D) agonist frovatriptan". Headache . 42 (Suppl 2): S47 – S53 . doi :10.1046/j.1526-4610.42.s2.2.x . PMID 12028320 .
^ a b Wellington K, Plosker GL (2002). "Rizatriptan: an update of its use in the management of migraine". Drugs . 62 (10): 1539– 74. doi :10.2165/00003495-200262100-00007 . PMID 12093318 . S2CID 195693597 .
^ a b "Rizatriptan" . PubChem . Retrieved 27 June 2025 .
^ "Rizatriptan: Uses, Interactions, Mechanism of Action" . DrugBank Online . 14 June 2012. Retrieved 27 June 2025 .
^ "Rishum01_5_982075622.pdf" (PDF) . Mohpublic.z6.web.core.windows.net . Retrieved 21 December 2023 .
^ "Maxalt Oral: Uses, Side Effects, Interactions, Pictures, Warnings & More" . WebMD . Archived from the original on 21 December 2023. Retrieved 21 December 2023 .
^ "Rizact 10 mg Tablet - Uses, Dosage, Side Effects, Composition" . Practo . Archived from the original on 21 December 2023. Retrieved 21 December 2023 .
5-HT1
5-HT1A
Agonists: 8-OH-DPAT
Adatanserin
Amphetamine
Antidepressants (e.g., etoperidone , hydroxynefazodone , nefazodone , trazodone , triazoledione , vilazodone , vortioxetine )
Atypical antipsychotics (e.g., aripiprazole , asenapine , brexpiprazole , cariprazine , clozapine , lurasidone , quetiapine , ziprasidone )
Azapirones (e.g., buspirone , eptapirone , gepirone , perospirone , tandospirone )
Bay R 1531
Befiradol
BMY-14802
Cannabidiol
Dimemebfe
Dopamine
Ebalzotan
Eltoprazine
Enciprazine
Ergolines (e.g., bromocriptine , cabergoline , dihydroergotamine , ergotamine , lisuride , LSD , methylergometrine (methylergonovine) , methysergide , pergolide )
F-11461
F-12826
F-13714
F-14679
F-15063
F-15599
Flesinoxan
Flibanserin
Flumexadol
Hypidone
Lesopitron
LY-293284
LY-301317
mCPP
MKC-242
Naluzotan
NBUMP
Osemozotan
Oxaflozane
Pardoprunox
Piclozotan
Rauwolscine
Repinotan
Roxindole
RU-24969
S-14506
S-14671
S-15535
Sarizotan
Serotonin (5-HT)
SSR-181507
Sunepitron
Tryptamines (e.g., 5-CT , 5-MeO-DMT , 5-MT , bufotenin , DMT , indorenate , N-Me-5-HT , psilocin , psilocybin )
TGBA01AD
U-92016-A
Urapidil
Vilazodone
Xaliproden
Yohimbine
Positive allosteric modulators: Oleamide
Antagonists: Atypical antipsychotics (e.g., iloperidone , risperidone , sertindole )
AV965
Beta blockers (e.g., alprenolol , carteolol , cyanopindolol , iodocyanopindolol , isamoltane , oxprenolol , penbutolol , pindobind , pindolol , propranolol , tertatolol )
BMY-7378
CSP-2503
Dotarizine
Ergolines (e.g., metergoline )
FCE-24379
Flopropione
GR-46611
Isamoltane
Lecozotan
Mefway
Metitepine (methiothepin)
MIN-117 (WF-516)
MPPF
NAN-190
Robalzotan
S-15535
SB-649915
SDZ 216-525
Spiperone
Spiramide
Spiroxatrine
UH-301
WAY-100135
WAY-100635
Xylamidine
5-HT1B
Agonists: Anpirtoline
CGS-12066A
CP-93129
CP-94253
CP-122288
CP-135807
Eltoprazine
Ergolines (e.g., bromocriptine , dihydroergotamine , ergotamine , methylergometrine (methylergonovine) , methysergide , pergolide )
mCPP
RU-24969
Serotonin (5-HT)
Triptans (e.g., avitriptan , donitriptan , eletriptan , sumatriptan , zolmitriptan )
TFMPP
Tryptamines (e.g., 5-BT , 5-CT , 5-MT , DMT )
Vortioxetine
5-HT1D
Agonists: CP-122288
CP-135807
CP-286601
Ergolines (e.g., bromocriptine , cabergoline , dihydroergotamine , ergotamine , LSD , methysergide )
GR-46611
L-694247
L-772405
mCPP
PNU-109291
PNU-142633
Serotonin (5-HT)
TGBA01AD
Triptans (e.g., almotriptan , avitriptan , donitriptan , eletriptan , frovatriptan , naratriptan , rizatriptan , sumatriptan , zolmitriptan )
Tryptamines (e.g., 5-BT , 5-CT , 5-Et-DMT , 5-MT , 5-(nonyloxy)tryptamine , DMT )
5-HT1E
5-HT1F
5-HT2
5-HT2A
Agonists: 25H/NB series (e.g., 25I-NBF , 25I-NBMD , 25I-NBOH , 25I-NBOMe , 25B-NBOMe , 25C-NBOMe , 25TFM-NBOMe , 2CBCB-NBOMe , 25CN-NBOH , 2CBFly-NBOMe )
2Cs (e.g., 2C-B , 2C-E , 2C-I , 2C-T-2 , 2C-T-7 , 2C-T-21 )
2C-B-FLY
2CB-Ind
5-Methoxytryptamines (5-MeO-DET , 5-MeO-DiPT , 5-MeO-DMT , 5-MeO-DPT , 5-MT )
α-Alkyltryptamines (e.g., 5-Cl-αMT , 5-Fl-αMT , 5-MeO-αET , 5-MeO-αMT , α-Me-5-HT , αET , αMT )
AL-34662
AL-37350A
Bromo-DragonFLY
Dimemebfe
DMBMPP
DOx (e.g., DOB , DOC , DOI , DOM )
Efavirenz
Ergolines (e.g., 1P-LSD , ALD-52 , bromocriptine , cabergoline , ergine (LSA) , ergometrine (ergonovine) , ergotamine , lisuride , LA-SS-Az , LSB , LSD , LSD-Pip , LSH , LSP , methylergometrine (methylergonovine) , pergolide )
Flumexadol
IHCH-7113
Jimscaline
Lorcaserin
MDxx (e.g., MDA (tenamfetamine) , MDMA (midomafetamine) , MDOH , MMDA )
O-4310
Oxaflozane
PHA-57378
PNU-22394
PNU-181731
RH-34
SCHEMBL5334361
Phenethylamines (e.g., lophophine , mescaline )
Piperazines (e.g., BZP , quipazine , TFMPP )
Serotonin (5-HT)
TCB-2
TFMFly
Tryptamines (e.g., 5-BT , 5-CT , bufotenin , DET , DiPT , DMT , DPT , psilocin , psilocybin , tryptamine )
Antagonists: 5-I-R91150
5-MeO-NBpBrT
AC-90179
Adatanserin
Altanserin
Antihistamines (e.g., cyproheptadine , hydroxyzine , ketotifen , perlapine )
AMDA
Atypical antipsychotics (e.g., amperozide , aripiprazole , asenapine , blonanserin , brexpiprazole , carpipramine , clocapramine , clorotepine , clozapine , fluperlapine , gevotroline , iloperidone , lurasidone , melperone , mosapramine , ocaperidone , olanzapine , paliperidone , quetiapine , risperidone , sertindole , zicronapine , ziprasidone , zotepine )
Chlorprothixene
Cinanserin
CSP-2503
Deramciclane
Dotarizine
Eplivanserin
Ergolines (e.g., amesergide , LY-53857 , LY-215840 , mesulergine , metergoline , methysergide , sergolexole )
Fananserin
Flibanserin
Glemanserin
Irindalone
Ketanserin
KML-010
Landipirdine
LY-393558
mCPP
Medifoxamine
Metitepine (methiothepin)
MIN-117 (WF-516)
Naftidrofuryl
Nantenine
Nelotanserin
Opiranserin (VVZ-149)
Pelanserin
Phenoxybenzamine
Pimavanserin
Pirenperone
Pizotifen
Pruvanserin
Rauwolscine
Ritanserin
Roluperidone
S-14671
Sarpogrelate
Serotonin antagonists and reuptake inhibitors (e.g., etoperidone , hydroxynefazodone , lubazodone , mepiprazole , nefazodone , triazoledione , trazodone )
SR-46349B
TGBA01AD
Teniloxazine
Temanogrel
Tetracyclic antidepressants (e.g., amoxapine , aptazapine , esmirtazapine , maprotiline , mianserin , mirtazapine )
Tricyclic antidepressants (e.g., amitriptyline )
Typical antipsychotics (e.g., chlorpromazine , fluphenazine , haloperidol , loxapine , perphenazine , pimozide , pipamperone , prochlorperazine , setoperone , spiperone , spiramide , thioridazine , thiothixene , trifluoperazine )
Volinanserin
Xylamidine
Yohimbine
5-HT2B
Agonists: 4-Methylaminorex
Aminorex
Amphetamines (e.g., chlorphentermine , cloforex , dexfenfluramine , fenfluramine , levofenfluramine , norfenfluramine )
BW-723C86
DOx (e.g., DOB , DOC , DOI , DOM )
Ergolines (e.g., cabergoline , dihydroergocryptine , dihydroergotamine , ergotamine , methylergometrine (methylergonovine) , methysergide , pergolide )
Lorcaserin
MDxx (e.g., MDA (tenamfetamine) , MDMA (midomafetamine) , MDOH , MMDA )
Piperazines (e.g., TFMPP )
PNU-22394
Ro60-0175
Serotonin (5-HT)
Tryptamines (e.g., 5-BT , 5-CT , 5-MT , α-Me-5-HT , bufotenin , DET , DiPT , DMT , DPT , psilocin , psilocybin , tryptamine )
Antagonists: Agomelatine
Atypical antipsychotics (e.g., amisulpride , aripiprazole , asenapine , brexpiprazole , cariprazine , clozapine , N-desalkylquetiapine (norquetiapine) , N-desmethylclozapine (norclozapine) , olanzapine , pipamperone , quetiapine , risperidone , ziprasidone )
Cyproheptadine
EGIS-7625
Ergolines (e.g., amesergide , bromocriptine , lisuride , LY-53857 , LY-272015 , mesulergine )
Ketanserin
LY-393558
mCPP
Metadoxine
Metitepine (methiothepin)
Pirenperone
Pizotifen
Propranolol
PRX-08066
Rauwolscine
Ritanserin
RS-127445
Sarpogrelate
SB-200646
SB-204741
SB-206553
SB-215505
SB-221284
SB-228357
SDZ SER-082
Tegaserod
Tetracyclic antidepressants (e.g., amoxapine , mianserin , mirtazapine )
Trazodone
Typical antipsychotics (e.g., chlorpromazine )
TIK-301
Yohimbine
5-HT2C
Agonists: 2Cs (e.g., 2C-B , 2C-E , 2C-I , 2C-T-2 , 2C-T-7 , 2C-T-21 )
5-Methoxytryptamines (5-MeO-DET , 5-MeO-DiPT , 5-MeO-DMT , 5-MeO-DPT , 5-MT )
α-Alkyltryptamines (e.g., 5-Cl-αMT , 5-Fl-αMT , 5-MeO-αET , 5-MeO-αMT , α-Me-5-HT , αET , αMT )
A-372159
AL-38022A
Alstonine
CP-809101
Dimemebfe
DOx (e.g., DOB , DOC , DOI , DOM )
Ergolines (e.g., ALD-52 , cabergoline , dihydroergotamine , ergine (LSA) , ergotamine , lisuride , LA-SS-Az , LSB , LSD , LSD-Pip , LSH , LSP , pergolide )
Flumexadol
Lorcaserin
MDxx (e.g., MDA (tenamfetamine) , MDMA (midomafetamine) , MDOH , MMDA )
MK-212
ORG-12962
ORG-37684
Oxaflozane
PHA-57378
Phenethylamines (e.g., lophophine , mescaline )
Piperazines (e.g., aripiprazole , BZP , mCPP , quipazine , TFMPP )
PNU-22394
PNU-181731
Ro60-0175
Ro60-0213
Serotonin (5-HT)
Tryptamines (e.g., 5-BT , 5-CT , bufotenin , DET , DiPT , DMT , DPT , psilocin , psilocybin , tryptamine )
Vabicaserin
WAY-629
WAY-161503
YM-348
Antagonists: Adatanserin
Agomelatine
Atypical antipsychotics (e.g., asenapine , clorotepine , clozapine , fluperlapine , iloperidone , melperone , olanzapine , paliperidone , quetiapine , risperidone , sertindole , ziprasidone , zotepine )
Captodiame
CEPC
Cinanserin
Cyproheptadine
Deramciclane
Desmetramadol
Dotarizine
Eltoprazine
Ergolines (e.g., amesergide , bromocriptine , LY-53857 , LY-215840 , mesulergine , metergoline , methysergide , sergolexole )
Etoperidone
Fluoxetine
FR-260010
Irindalone
Ketanserin
Ketotifen
Latrepirdine (dimebolin)
Medifoxamine
Metitepine (methiothepin)
Nefazodone
Pirenperone
Pizotifen
Propranolol
Ritanserin
RS-102221
S-14671
SB-200646
SB-206553
SB-221284
SB-228357
SB-242084
SB-243213
SDZ SER-082
Tedatioxetine
Tetracyclic antidepressants (e.g., amoxapine , aptazapine , esmirtazapine , maprotiline , mianserin , mirtazapine )
TIK-301
Tramadol
Trazodone
Tricyclic antidepressants (e.g., amitriptyline , nortriptyline )
Typical antipsychotics (e.g., chlorpromazine , loxapine , pimozide , pipamperone , thioridazine )
Xylamidine
5-HT3 –7
5-HT3
Agonists: Alcohols (e.g., butanol , ethanol (alcohol) , trichloroethanol )
m-CPBG
Phenylbiguanide
Piperazines (e.g., BZP , mCPP , quipazine )
RS-56812
Serotonin (5-HT)
SR-57227
SR-57227A
Tryptamines (e.g., 2-Me-5-HT , 5-CT , bufotenidine (5-HTQ) )
Volatiles/gases (e.g., halothane , isoflurane , toluene , trichloroethane )
YM-31636
Antagonists: Alosetron
Anpirtoline
Arazasetron
AS-8112
Atypical antipsychotics (e.g., clozapine , olanzapine , quetiapine )
Azasetron
Batanopride
Bemesetron (MDL-72222)
Cilansetron
CSP-2503
Dazopride
Dolasetron
Galanolactone
Granisetron
Lerisetron
Memantine
Ondansetron
Palonosetron
Ramosetron
Renzapride
Ricasetron
Tedatioxetine
Tetracyclic antidepressants (e.g., amoxapine , mianserin , mirtazapine )
Thujone
Tropanserin
Tropisetron
Typical antipsychotics (e.g., loxapine )
Volatiles/gases (e.g., nitrous oxide , sevoflurane , xenon )
Vortioxetine
Zacopride
Zatosetron
5-HT4
5-HT5A
5-HT6
Agonists: Ergolines (e.g., dihydroergocryptine , dihydroergotamine , ergotamine , lisuride , LSD , mesulergine , metergoline , methysergide )
Hypidone
Serotonin (5-HT)
Tryptamines (e.g., 2-Me-5-HT , 5-BT , 5-CT , 5-MT , Bufotenin , E-6801 , E-6837 , EMD-386088 , EMDT , LY-586713 , N-Me-5-HT , ST-1936 , tryptamine )
WAY-181187
WAY-208466
Antagonists: ABT-354
Atypical antipsychotics (e.g., aripiprazole , asenapine , clorotepine , clozapine , fluperlapine , iloperidone , olanzapine , tiospirone )
AVN-101
AVN-211
AVN-322
AVN-397
BGC20-760
BVT-5182
BVT-74316
Cerlapirdine
EGIS-12233
GW-742457
Idalopirdine
Ketanserin
Landipirdine
Latrepirdine (dimebolin)
Masupirdine
Metitepine (methiothepin)
MS-245
PRX-07034
Ritanserin
Ro 04-6790
Ro 63-0563
SB-258585
SB-271046
SB-357134
SB-399885
SB-742457
Tetracyclic antidepressants (e.g., amoxapine , mianserin )
Tricyclic antidepressants (e.g., amitriptyline , clomipramine , doxepin , nortriptyline )
Typical antipsychotics (e.g., chlorpromazine , loxapine )
5-HT7
Antagonists: Atypical antipsychotics (e.g., amisulpride , aripiprazole , asenapine , brexpiprazole , clorotepine , clozapine , fluperlapine , olanzapine , risperidone , sertindole , tiospirone , ziprasidone , zotepine )
Butaclamol
DR-4485
EGIS-12233
Ergolines (e.g., 2-Br-LSD (BOL-148) , amesergide , bromocriptine , cabergoline , dihydroergotamine , ergotamine , LY-53857 , LY-215840 , mesulergine , metergoline , methysergide , sergolexole )
JNJ-18038683
Ketanserin
LY-215840
Metitepine (methiothepin)
Ritanserin
SB-258719
SB-258741
SB-269970
SB-656104
SB-656104A
SB-691673
SLV-313
SLV-314
Spiperone
SSR-181507
Tetracyclic antidepressants (e.g., amoxapine , maprotiline , mianserin , mirtazapine )
Tricyclic antidepressants (e.g., amitriptyline , clomipramine , imipramine )
Typical antipsychotics (e.g., acetophenazine , chlorpromazine , chlorprothixene , fluphenazine , loxapine , pimozide )
Vortioxetine
Negative allosteric modulators: Oleamide
Tryptamines 4-Hydroxytryptamines and esters /ethers 5-Hydroxy- and5-methoxytryptamines
2-Methyl-5-HT
4-HO-5-MeO-T
4-F-5-MeO-DMT
4,5-DHP-DMT
4,5-DHT
4,5-MDO-DMT
4,5-MDO-DiPT
5-BT
5-Ethoxy-DMT
5-HO-DET
5-HO-DiPT
5-HO-NiPT
5-HO-DPT
5-HTP (oxitriptan )
5-MeO-2-TMT
5-MeO-34MPEMT
5-MeO-7,N ,N -TMT
5-MeO-DALT
5-MeO-DBT
5-MeO-DET
5-MeO-DiPT
5-MeO-DMT (N ,N ,O -TMS; O -methylbufotenine)
5-MeO-DPT
5-MeO-EiPT
5-MeO-EPT
5-MeO-MALT
5-MeO-MET
5-MeO-MiPT
5-MeO-NET
5-MeO-NiPT
5-MeO-NMT (O ,N -DMS)
5-MeO-PiPT
5-MeO-NBpBrT
5-MeO-T (5-MT; mexamine; O -methylserotonin)
5-MeO-T-NBOMe
5-MT-NB3OMe
5-NOT
5,6-DHT
5,6-MDO-DiPT
5,6-MDO-DMT
5,6-MDO-MiPT
5,6-MeO-MiPT
5,7-DHT
Arachidonoyl serotonin
ASR-3001 (5-MeO-iPALT)
BAB
Benanserin (BAS; SQ-4788)
BGC20-761
Bufotenidine (5-HTQ; N ,N ,N -TMS)
Bufotenin (5-HO-DMT; N ,N -DMS; mappine)
Bufoviridine (5-SO-DMT)
CP-132,484
Cqd 280
Cqd 285
Cqdd 280
Donitriptan
EMDT (2-Et-5-MeO-DMT)
HIOC
Indorenate (TR-3369)
Isamide (N -CA-5-MT)
L-741604
MS-245
N -DEAOP-5-MeO-NET
N -DEAOP-5-MeO-NMT
N -Feruloylserotonin (moschamine)
Norbufotenin (5-HO-NMT; NMS)
O -Acetylbufotenine (5-AcO-DMT)
O -Pivalylbufotenine (5-(t -BuCO)-DMT)
Psilomethoxin (4-HO-5-MeO-DMT)
Psilomethoxybin (4-PO-5-MeO-DMT)
Serotonin (5-HT)
N -Acetyltryptaminesα-Alkyltryptamines
5-Hydroxy- and 5-alkoxy-α-alkyltryptamines: 1-Pr-5-MeO-AMT
5-Allyloxy-AMT
5-Ethoxy-αMT
5-iPrO-αMT
5-MeO-αET
5-MeO-αMT (α,O -DMS; Alpha-O)
α-Methyl-5-HTP
α-Methylmelatonin
α-Methylserotonin (5-HO-αMT; α-Me-5-HT)
α,N ,O -TMS (5-MeO-α,N -DMT)
α,N ,N ,O -TeMS (5-MeO-α,N ,N -TMT)
AL-37350A (4,5-DHP-αMT)
BW-723C86
Cyclized tryptamines
Barettin
Cyclic 3-OHM
Ergolines and lysergamides (e.g., LSD )
Harmala alkaloids and β-carbolines (e.g., 5-methoxyharmalan , 6-MeO-THH , 6-methoxyharmalan , 9-Me-BC , β-carboline (norharman) , fenharmane , harmaline , harmalol , harmane , harmine , LY-266,097 , pinoline , tetrahydroharmine , tryptoline )
Iboga alkaloids (e.g., ibogaine , ibogamine , noribogaine , tabernanthine )
Ibogalogs (e.g., catharanthalog , fluorogainalog , ibogainalog , ibogaminalog (DM-506) , LS-22925 , noribogainalog , noribogaminalog , PHA-57378 , PNU-22394 , tabernanthalog )
Imidazolylindoles (e.g., AGH-107 , AGH-192 , AH-494 )
Metralindole
Partial ergolines and lysergamides (e.g., NDTDI , RU-27849 , RU-28251 , RU-28306 , FHATHBIN , LY-178210 , Bay R 1531 (LY-197206) , LY-293284 , 10,11-seco-LSD , 10,11-secoergoline (α,N -Pip-T) , CT-5252 )
Pertines (e.g., alpertine , milipertine , oxypertine , solypertine )
Piperidinylethylindoles (e.g., pip-T , indolylethylfentanyl )
Pyrrolidinylethylindoles (e.g., pyr-T , 4-HO-pyr-T , 5-MeO-pyr-T , 4-F-5-MeO-pyr-T )
Pyrrolidinylmethylindoles (e.g., MPMI , 4-HO-MPMI (lucigenol) , 5F-MPMI , 5-MeO-MPMI , CP-122288 , CP-135807 , eletriptan )
Tetrahydrocarbazolamines (e.g., ciclindole , flucindole , frovatriptan , LY-344864 , ramatroban )
Tetrahydropyridinylindoles (e.g., RS134-49 , RU-28253 )
Tetrahydropyrroloquinolines (e.g., bufothionine , O -methylnordehydrobufotenine )
Yohimbans (e.g., yohimbine , rauwolscine , spegatrine , corynanthine , ajmalicine , reserpine , deserpidine , rescinnamine )
Isotryptamines Related compounds
2-Azapsilocin
4-Aza-5-MeO-DPT
5-Aza-4-MeO-DiPT
5-HIAA
5-HIAL
5-HITCA
5-MIAL
7-Aza-5-MeO-DiPT
α-Carboline
γ-Carbolines (pyridoindoles) (e.g., γ-carboline , alosetron , gevotroline , latrepirdine , lurosetron , mebhydrolin , tiflucarbine )
Amedalin
Benzindopyrine
Benzofurans (e.g., 3-APB , 5-MeO-DiBF , BPAP , 3-F-BPAP , dimemebfe , mebfap , oxa-noribogaine )
Benzothiophenes (e.g., 3-APBT )
Carmoxirole
CT-4436
Daledalin
Gramine
Histamine
I-32
IAL
IN-399
Indazolethylamines (e.g., AL-34662 , AL-38022A , O -methyl-AL-34662 , VU6067416 , YM-348 )
Indenylethylamines (e.g., C-DMT )
Indolizinylethylamines (e.g., TACT908 (2ZEDMA) , 1ZP2MA , 1Z2MAP1O )
Indolylaminopropanes (e.g., 1-API , 2-API , 4-API , 5-API (5-IT; PAL-571) , 6-API (6-IT) , 7-API )
Iprindole
Masupirdine
Medmain
Molindone
Non-tryptamine triptans (e.g., avitriptan , LY-334370 , naratriptan )
Ondansetron
Oxazinopyridoindoles (e.g., IHCH-8134 )
Phenethylamines (e.g., phenethylamine , amphetamine )
Piperidinylindoles (e.g., BRL-54443 , LY-334370 , naratriptan , sertindole , SN-22 )
Pirlindole
Pyridinylindoles (e.g., tepirindole )
Pyridopyrroloquinoxalines (e.g., IHCH-7113 , IHCH-7079 , IHCH-7086 , lumateperone , deulumateperone , ITI-1549 )
Pyrrolylethylamines (e.g., 2-pyrrolylethylamine (NEA) , 3-pyrrolylethylamine (3-NEA) , 3-pyrrolylpropylamine )
Pyrrolopyridinylethylamines (e.g., WAY-208466 )
Quinolinylethylamines (e.g., mefloquine )
Ro60-0213
Selisistat
Tetrahydropyridinylindoles (e.g., EMD-386088 , LY-367265 , RU-24,969 )
Tetrahydropyridinylpyrrolopyridines (e.g., (R )-69 (3IQ) , (R )-70 , CP-94253 )
Tetrindole
Tipindole
Zilpaterol (RU-42173)
Corporate directors Subsidiaries Products
Facilities Publications